Intravesical injection of botulinum toxin A for treatment of overactive bladder in anticoagulated patients: Is it safe?
Hannah WellsOliver William LutonAndrew J SimpkinNicholas BullockGokul Vignesh KandaswamyAyman YounisPublished in: Turkish journal of urology (2020)
Anticoagulated patients undergoing intravesical injections have higher complication risks; however, the treatment outcome is unaffected with no significant morbidity/mortality. This is the first study to demonstrate safe outcomes for this subgroup and can assist in decision making and consenting.
Keyphrases
- botulinum toxin
- patients undergoing
- end stage renal disease
- decision making
- ejection fraction
- chronic kidney disease
- newly diagnosed
- ultrasound guided
- muscle invasive bladder cancer
- cardiovascular events
- prognostic factors
- cardiovascular disease
- risk factors
- type diabetes
- metabolic syndrome
- coronary artery disease
- urinary tract
- adipose tissue
- insulin resistance
- phase iii